hKCa3/KCNN3 small conductance calcium activated potassium channel: a
diagnostic marker and therapeutic target
    3.
    发明授权
    hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target 失效
    hKCa3 / KCNN3小电导钙激活钾通道:诊断标记和治疗靶点

    公开(公告)号:US6165719A

    公开(公告)日:2000-12-26

    申请号:US115446

    申请日:1998-07-14

    摘要: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided. A method of treating a subject having or at risk of having an hKCa3/KCNN3-associated disorder by administering a therapeutically effective amount of a polynucleotide encoding SEQ ID NO:2 is also provided. A formulation for administration of hKCa3/KCNN3 to a patient of a therapeutically effective amount of hKCa3/KCNN3 polypeptide is provided. Kits useful for detecting the presence of hKCa3/KCNN3 polypeptide or polynucleotide in a sample from a subject having a hKCa3/KCNN3-associated disorder are provided. Transgenic nonhuman animals having a transgene encoding hKCa3/KCNN3 are also described.

    摘要翻译: 本发明是基于在神经细胞,骨骼肌,心脏和淋巴细胞中表达的人小电导钙激活钾通道3型(hKCa3 / KCNN3)基因的发现和克隆。 hKCa3 / KCNN3基因或其蛋白质产物的改变可能增加对精神分裂症和/或双相情感障碍的易感性。 hKCa3 / KCNN3可能参与神经精神,神经,神经肌肉和免疫疾病。 提供了大量纯化的hKCa3 / KNN3多肽和多核苷酸。 还公开了与hKCa3 / KCNN3多肽结合的抗体。 提供了鉴定影响hKCa3 / KCNN3多核苷酸或多肽的化合物的方法。 还提供了用于诊断和确定具有hKCa3 / KCNN3相关病症或具有hKCa3 / KCNN3相关病症风险的受试者的预后和治疗方案的方法。 还提供了通过施用治疗有效量的编码SEQ ID NO:2的多核苷酸治疗患有或具有hKCa3 / KCNN3相关病症风险的受试者的方法。 提供了将hKCa3 / KCNN3给予治疗有效量的hKCa3 / KCNN3多肽的患者的制剂。 提供了可用于检测来自具有hKCa3 / KCNN3相关病症的受试者的样品中hKCa3 / KCNN3多肽或多核苷酸的存在的试剂盒。 还描述了具有编码hKCa3 / KCNN3的转基因的转基因非人动物。

    X-ray system with implantable needle for treatment of cancer

    公开(公告)号:US06580940B2

    公开(公告)日:2003-06-17

    申请号:US09776559

    申请日:2001-02-02

    申请人: George Gutman

    发明人: George Gutman

    IPC分类号: A61N510

    摘要: An x-ray system for treatment cancer by delivering x-ray radiation directly to a desired region of tissue comprising an x-ray source with directed narrow space distribution of x-rays (linear accelerator), conditioning optics which direct and monochromotize x-ray radiation, an implantable needle with means for shaping beam installed across the x-ray beam, and expanding pipe-guide connecting conditioning optics with implantable needle whereby the energy, intensity, and space distribution of the delivered to the tumor x-ray radiation may be adjusted in accordance with the predefined treatment requirements.

    Optical element of multilayered thin film for X-rays and neutrons
    5.
    发明授权
    Optical element of multilayered thin film for X-rays and neutrons 失效
    用于X射线和中子的多层薄膜的光学元件

    公开(公告)号:US5646976A

    公开(公告)日:1997-07-08

    申请号:US487936

    申请日:1995-06-07

    申请人: George Gutman

    发明人: George Gutman

    IPC分类号: G21K1/06

    摘要: This invention relates to novel methods of producing flat and curved optical elements with laterally and depth graded multilayer thin films, in particular multilayers of extremely high precision, for use with soft and hard x-rays and neutrons and the optical elements achieved by these methods. In order to improve the performance of an optical element, errors in d spacing and curvature are isolated and subsequently compensated.

    摘要翻译: 本发明涉及生产具有横向和深度梯度多层薄膜的平面和弯曲光学元件的新方法,特别是具有极高精度的多层,用于软和硬x射线和中子以及通过这些方法实现的光学元件。 为了提高光学元件的性能,分离出d间隔和曲率的误差并随后进行补偿。

    hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target
    6.
    发明授权
    hKCa3/KCNN3 small conductance calcium activated potassium channel: a diagnostic marker and therapeutic target 有权
    hKCa3 / KCNN3小电导钙激活钾通道:诊断标记和治疗靶点

    公开(公告)号:US07378496B2

    公开(公告)日:2008-05-27

    申请号:US10722189

    申请日:2003-11-24

    IPC分类号: C07K14/705

    摘要: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KCNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided. A method of treating a subject having or at risk of having an hKCa3/KCNN3-associated disorder by administering a therapeutically effective amount of a polynucleotide encoding SEQ ID NO:2 is also provided. A formulation for administration of hKCa3/KCNN3 to a patient of a therapeutically effective amount of hKCa3/KCNN3 polypeptide is provided. Kits useful for detecting the presence of hKCa3/KCNN3 polypeptide or polynucleotide in a sample from a subject having a hKCa3/KCNN3-associated disorder are provided. Transgenic nonhuman animals having a transgene encoding hKCa3/KCNN3 are also described.

    摘要翻译: 本发明是基于在神经细胞,骨骼肌,心脏和淋巴细胞中表达的人小电导钙激活钾通道3型(hKCa3 / KCNN3)基因的发现和克隆。 hKCa3 / KCNN3基因或其蛋白质产物的改变可能增加对精神分裂症和/或双相情感障碍的易感性。 hKCa3 / KCNN3可能参与神经精神,神经,神经肌肉和免疫疾病。 提供了大量纯化的hKCa3 / KCNN3多肽和多核苷酸。 还公开了与hKCa3 / KCNN3多肽结合的抗体。 提供了鉴定影响hKCa3 / KCNN3多核苷酸或多肽的化合物的方法。 还提供了用于诊断和确定具有hKCa3 / KCNN3相关病症或具有hKCa3 / KCNN3相关病症风险的受试者的预后和治疗方案的方法。 还提供了通过施用治疗有效量的编码SEQ ID NO:2的多核苷酸治疗患有或具有hKCa3 / KCNN3相关病症风险的受试者的方法。 提供了将hKCa3 / KCNN3给予治疗有效量的hKCa3 / KCNN3多肽的患者的制剂。 提供了可用于检测来自具有hKCa3 / KCNN3相关病症的受试者的样品中hKCa3 / KCNN3多肽或多核苷酸的存在的试剂盒。 还描述了具有编码hKCa3 / KCNN3的转基因的转基因非人动物。

    X-ray needle apparatus and method for radiation treatment
    7.
    发明申请
    X-ray needle apparatus and method for radiation treatment 审中-公开
    X射线针装置及放射治疗方法

    公开(公告)号:US20060133575A1

    公开(公告)日:2006-06-22

    申请号:US11190424

    申请日:2005-07-27

    摘要: The invention is directed to an x-ray device and method for radiation treatment comprising an x-ray source 1, a collimator 4 incorporating conditional optics, such as a capillary lens 3 for directing and focusing the x-ray radiation, and implantable needles. One or more capillary semilenses 16, 17 are positioned along the optical axis of the x-ray beam allow to form a movable focus by changing the distance between the semilenses. The input end of the collimator 4 is optically and mechanically conjugated with the x-ray source 1. The output end of the collimator is optically and mechanically conjugated with an originating end of the needle 5. At its output end is a transparent window 6 on which can repose a layer 13 that substantially absorbs and re-emits radiation which passes through the window 6.

    摘要翻译: 本发明涉及一种用于放射线治疗的X射线装置和方法,其包括x射线源1,包括条件光学元件的准直仪4,例如用于引导和聚焦x射线辐射的毛细管透镜3以及可植入的针。 一个或多个毛细管半纤维16,17沿X射线束的光轴定位允许通过改变半固体之间的距离来形成可移动聚焦。 准直器4的输入端与X射线源1光学和机械共轭。准直器的输出端与针5的起始端光学和机械共轭。其输出端为透明窗6, 其可以放置基本上吸收和再发射穿过窗口6的辐射的层13。

    hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target
    8.
    发明授权
    hKCa3/KCNN3 small conductance calcium activated potassium channel: A diagnostic marker and therapeutic target 失效
    hKCa3 / KCNN3小电导钙激活钾通道:诊断标志物和治疗靶标

    公开(公告)号:US06653100B1

    公开(公告)日:2003-11-25

    申请号:US09565590

    申请日:2000-05-04

    IPC分类号: C12N1512

    摘要: The present invention is based on the discovery and cloning of the human small conductance calcium activated potassium channel type 3 (hKCa3/KCNN3) gene, which is expressed in neuronal cells, skeletal muscle, heart, and lymphocytes. Alterations in the hKCa3/KCNN3 gene or its protein product may enhance susceptibility to schizophrenia and/or bipolar disorder. hKCa3/KCNN3 may be involved in neuropsychiatric, neurological, neuromuscular, and immunological disorders. Substantially purified hKCa3/KCNN3 polypeptides and polynucleotides are provided. Antibodies which bind to hKCa3/KCNN3 polypeptides are also disclosed. A method for identifying a compound which affects hKCa3/KCNN3 polynucleotide or polypeptide is provided. A method for diagnosis and determining the prognosis and treatment regimen of a subject having or at risk of having a hKCa3/KCNN3-associated disorder is also provided. A method of treating a subject having or at risk of having an hKCa3/KCNN3-associated disorder by administering a therapeutically effective amount of a polynucleotide encoding SEQ ID NO:2 is also provided. A formulation for administration of hKCa3/KCNN3 to a patient of a therapeutically effective amount of hKCa3/KCNN3 polypeptide is provided. Kits useful for detecting the presence of hKCa3/KCNN3 polypeptide or polynucleotide in a sample from a subject having a hKCa3/KCNN3-associated disorder are provided. Transgenic nonhuman animals having a transgene encoding hKCa3/KCNN3 are also described.

    摘要翻译: 本发明是基于在神经细胞,骨骼肌,心脏和淋巴细胞中表达的人小电导钙激活钾通道3型(hKCa3 / KCNN3)基因的发现和克隆。 hKCa3 / KCNN3基因或其蛋白质产物的改变可能增加对精神分裂症和/或双相情感障碍的易感性。 hKCa3 / KCNN3可能参与神经精神,神经,神经肌肉和免疫疾病。 提供了大量纯化的hKCa3 / KCNN3多肽和多核苷酸。 还公开了与hKCa3 / KCNN3多肽结合的抗体。 提供了鉴定影响hKCa3 / KCNN3多核苷酸或多肽的化合物的方法。 还提供了用于诊断和确定具有hKCa3 / KCNN3相关病症或具有hKCa3 / KCNN3相关病症风险的受试者的预后和治疗方案的方法。 还提供了通过施用治疗有效量的编码SEQ ID NO:2的多核苷酸治疗患有或具有hKCa3 / KCNN3相关病症风险的受试者的方法。 提供了将hKCa3 / KCNN3给予治疗有效量的hKCa3 / KCNN3多肽的患者的制剂。 提供了可用于检测来自具有hKCa3 / KCNN3相关病症的受试者的样品中hKCa3 / KCNN3多肽或多核苷酸的存在的试剂盒。 还描述了具有编码hKCa3 / KCNN3的转基因的转基因非人动物。

    Apparatus and method for generating a high intensity X-ray beam with a selectable shape and wavelength
    10.
    发明授权
    Apparatus and method for generating a high intensity X-ray beam with a selectable shape and wavelength 有权
    用于产生具有可选形状和波长的高强度X射线束的装置和方法

    公开(公告)号:US06493421B2

    公开(公告)日:2002-12-10

    申请号:US09974255

    申请日:2001-10-09

    申请人: George Gutman

    发明人: George Gutman

    IPC分类号: G21K106

    CPC分类号: G21K1/06 H01J35/00 H05G2/00

    摘要: An X-ray source is provided for delivering a high intensity X-ray beam with a predefined energy level of monochromatization, intensity and spatial distribution to a desired region of a sample. The source includes a linear accelerator with a thin anode 4, an electron trap 5 for separating an electron beam from an X-ray beam and conditioning optics which direct, shape and monochromatize the X-ray beam. The conditioning optics include a housing 8 within which are contained entrance slits, multi layer Kirkpatrick-Baez mirrors, exit slits, and a stop diaphragm. The invention also include a method of generating X-rays and a method of using them.

    摘要翻译: 提供X射线源,用于将具有预定能量水平的单色化,强度和空间分布的高强度X射线束传送到样品的期望区域。 源包括具有薄阳极的线性加速器4,用于从X射线束分离电子束的电子阱5和引导,形状和单色化X射线束的调节光学器件。 调理光学元件包括壳体8,其中包含入口狭缝,多层Kirkpatrick-Baez镜,出口狭缝和止动膜片。 本发明还包括产生X射线的方法及其使用方法。